StockWatch
·
Misc Health and Biotechnology Services
Loan & DebtJun 8, 2026, 04:37 PM

DaVita Secures $500M Incremental Term Loan

AI Summary

DaVita Inc. entered into a Ninth Amendment to its Credit Agreement, securing an incremental $500 million under its Tranche B-2 Term Facility maturing in May 2031. The proceeds will be used to repay a portion of its outstanding senior secured revolving loan facility, cover associated fees, and for general corporate purposes. Additionally, the company held its 2026 Annual Meeting of Stockholders on June 4, 2026, where nine director nominees were elected to the Board of Directors.

Key Highlights

  • Secured $500 million incremental borrowing under the Tranche B-2 Term Facility.
  • The incremental loan matures in May 2031.
  • Proceeds will be used to repay a portion of the outstanding senior secured revolving loan facility and for general corporate purposes.
  • Interest rate based on Base Rate plus 75 basis points or Term SOFR plus 175 basis points.
  • Held 2026 Annual Meeting of Stockholders on June 4, 2026.
  • Approximately 91% of outstanding shares (59,865,902 shares) were represented at the Annual Meeting.
  • Nine director nominees were elected to the Board of Directors.